Swedish Ophthalmological Society

Article

Swedish ophthalmologic research has a long tradition dating back to the slit lamp of Gullstrand of the early 20th century through later concepts such as the use of sodium hyaluronate in cataract surgery and latanoprost in glaucoma treatment. University departments of ophthalmology are present at the Karolinska Institute in Stockholm and at the universities of Uppsala, Lund (Lund and Malm?), Link?ping, Gothenburg and Ume?.

Swedish ophthalmologic research has a long tradition dating back to the slit lamp of Gullstrand of the early 20th century through later concepts such as the use of sodium hyaluronate in cataract surgery and latanoprost in glaucoma treatment. University departments of ophthalmology are present at the Karolinska Institute in Stockholm and at the universities of Uppsala, Lund (Lund and Malmö), Linköping, Gothenburg and Umeå.

International cooperation is promoted through the participation at the biannual Nordic Congresses of Ophthalmology, membership in the Nordic Ophthalmologic Committee and Acta Ophthalmologica Foundation. More recently, a European leadership development programme specifically designed for ophthalmologists has been implemented by representatives of the society within the framework of the European Society of Ophthalmology (SOE).

For more information please visit http://www.swedeye.org/

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.